We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

Fund managers haven’t disclosed any holdings of KYTH yet.

KYTH Hedge Fund Activity: Q4 2015 in Review

0 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2015, worth a combined $0 — down 100% from $1.61B a quarter earlier.

Sellers outnumbered buyers: 142 funds closed out of KYTH and 0 opened new positions — a net loss of 142 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Jennison Associates, exiting entirely with an estimated $119M sold.

  • 0 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2015, down from 143 in Q3 2015.
  • Funds reported $0 of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2015, down 100% quarter-over-quarter.
  • 0 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2015 and 142 closed out, a net change of -142 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2015 was Jennison Associates, an estimated $119M sold.

Based on aggregated 13F filings for Q4 2015.